369 related articles for article (PubMed ID: 33910208)
1. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U
J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208
[TBL] [Abstract][Full Text] [Related]
2. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
[TBL] [Abstract][Full Text] [Related]
3. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
4. A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
Jiang BH; Maruyama J; Yokochi A; Mitani Y; Maruyama K
Lung; 2007; 185(5):303-308. PubMed ID: 17721804
[TBL] [Abstract][Full Text] [Related]
5. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
6. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
8. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
Leong ZP; Hikasa Y
Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
10. Continuous inhalation of carbon monoxide induces right ventricle ischemia and dysfunction in rats with hypoxic pulmonary hypertension.
Gautier M; Antier D; Bonnet P; Le Net JL; Hanton G; Eder V
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1046-52. PubMed ID: 17483237
[TBL] [Abstract][Full Text] [Related]
11. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
12. BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.
Thorsen LB; Eskildsen-Helmond Y; Zibrandtsen H; Stasch JP; Simonsen U; Laursen BE
Eur J Pharmacol; 2010 Nov; 647(1-3):147-54. PubMed ID: 20828552
[TBL] [Abstract][Full Text] [Related]
13. Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
Darwiche T; Collum SD; Bi W; Reynolds JO; Wilson C; Wareing N; Hernandez AM; Mertens TCJ; Zhou Z; Pandit LM; Karmouty-Quintana H
Exp Physiol; 2019 Apr; 104(4):568-579. PubMed ID: 30663834
[TBL] [Abstract][Full Text] [Related]
14. Cystamine slows but not inverses the progression of monocrotaline-induced pulmonary arterial hypertension in rats.
Wang HM; Liu WZ; Tang FT; Sui HJ; Zhan XJ; Wang HX
Can J Physiol Pharmacol; 2018 Aug; 96(8):783-789. PubMed ID: 29633623
[TBL] [Abstract][Full Text] [Related]
15. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.
Clements RT; Vang A; Fernandez-Nicolas A; Kue NR; Mancini TJ; Morrison AR; Mallem K; McCullough DJ; Choudhary G
Circ Heart Fail; 2019 Nov; 12(11):e005819. PubMed ID: 31707802
[TBL] [Abstract][Full Text] [Related]
17. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
18. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
19. Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.
Cotroneo E; Ashek A; Wang L; Wharton J; Dubois O; Bozorgi S; Busbridge M; Alavian KN; Wilkins MR; Zhao L
Circ Res; 2015 May; 116(10):1680-90. PubMed ID: 25767292
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.
Fried ND; Morris TM; Whitehead A; Lazartigues E; Yue X; Gardner JD
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1526-H1534. PubMed ID: 33577434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
